Embolus Prevention: Anticoagulant Therapy in Comparison to Watchman's Procedure in Patients with Atrial Fibrillation

Authors

Erik Fladmo, University of North Dakota

Files

Document Type

Poster

Description

• Atrial fibrillation or A-fib is a common cardiac disease that occurs as individuals get older.

• A risk factor of atrial fibrillation is blood clot formation and dislodgement or ‘embolus’ in the left atrium.

• Current treatment methods to prevent clot formation include anticoagulants, as well as a left atrial appendage closure device, The Watchman’s device is the only FDA approved left atrial appendage closure device.

• Study results confirm the rising efficacy and cost effectiveness of Watchman’s device versus long term anticoagulant therapy as well as their adverse effects regarding placement and post procedure; however further randomized control trials are needed to compare both therapies particularly novel oral anticoagulants head to head rather than through extrapolation.

• Long term effects of Watchman’s device need to be studied.

Department

Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

Publication Date

2019

Disciplines

Cardiovascular Diseases

Recommended Citation

Fladmo, Erik, "Embolus Prevention: Anticoagulant Therapy in Comparison to Watchman's Procedure in Patients with Atrial Fibrillation" (2019). Physician Assistant Scholarly Project Posters. 138.
https://commons.und.edu/pas-grad-posters/138